AC
Ascend Capital Portfolio holdings
AUM
$1.99B
1-Year Return
10.47%
This Quarter Return
+5.95%
1 Year Return
+10.47%
3 Year Return
+55.79%
5 Year Return
+85.99%
10 Year Return
–
AUM
$2.65B
AUM Growth
+$502M
(+23%)
Cap. Flow
+$140M
Cap. Flow
% of AUM
5.27%
Top 10 Holdings %
Top 10 Hldgs %
26.96%
Holding
219
New
70
Increased
41
Reduced
38
Closed
54
Top Buys
| 1 |
Puma Biotechnology
PBYI
|
$78.6M |
| 2 |
Host Hotels & Resorts
HST
|
$62.6M |
| 3 |
Prudential Financial
PRU
|
$60.6M |
| 4 |
ANDV
Andeavor
ANDV
|
$51.5M |
| 5 |
Viatris
VTRS
|
$45.6M |
Top Sells
| 1 |
MetLife
MET
|
$57.4M |
| 2 |
Pfizer
PFE
|
$34.1M |
| 3 |
Tapestry
TPR
|
$32.5M |
| 4 |
Meta Platforms (Facebook)
META
|
$31.5M |
| 5 |
Kraft Heinz
KHC
|
$27.9M |
Sector Composition
| 1 | Consumer Discretionary | 14.41% |
| 2 | Healthcare | 14.35% |
| 3 | Technology | 11.67% |
| 4 | Energy | 8.22% |
| 5 | Materials | 7.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
FOMX
126
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $2.22M | 0.08% |
+399,186
| New | +$2.22M |
|
|
MNK
127
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $2.2M | 0.08% |
58,999
-683,660
| -92% | -$25.5M |
|
128
Masimo
MASI
$7.75B
| $2.19M | 0.08% |
+25,315
| New | +$2.19M |
|
|
FPRX
129
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $2.07M | 0.08% |
+50,630
| New | +$2.07M |
|
|
CMRX
130
DELISTED
Chimerix, Inc.
CMRX
| $1.86M | 0.07% |
+355,353
| New | +$1.86M |
|
131
Netflix
NFLX
$533B
| $1.83M | 0.07% |
+10,088
| New | +$1.83M |
|
|
WRK
132
DELISTED
WestRock Company
WRK
| $1.74M | 0.07% |
+30,568
| New | +$1.74M |
|
133
AnaptysBio
ANAB
$585M
| $1.55M | 0.06% |
+44,375
| New | +$1.55M |
|
134
Howard Hughes
HHH
$4.58B
| $1.43M | 0.05% |
+12,693
| New | +$1.43M |
|
|
ARAV
135
DELISTED
Aravive, Inc. Common Stock
ARAV
| $1.29M | 0.05% |
+87,738
| New | +$1.29M |
|
136
Sealed Air
SEE
$4.76B
| $1.15M | 0.04% |
26,837
-181,720
| -87% | -$7.76M |
|
137
Veracyte
VCYT
$2.44B
| $1.08M | 0.04% |
+123,276
| New | +$1.08M |
|
|
KDNY
138
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $1.08M | 0.04% |
+20,252
| New | +$1.08M |
|
139
Take-Two Interactive
TTWO
$44.3B
| $1.03M | 0.04% |
+10,126
| New | +$1.03M |
|
140
Rigel Pharmaceuticals
RIGL
$720M
| $1.02M | 0.04% |
+40,252
| New | +$1.02M |
|
141
BioMarin Pharmaceuticals
BMRN
$10.9B
| $943K | 0.04% |
10,126
-151,508
| -94% | -$14.1M |
|
142
Viking Therapeutics
VKTX
$2.96B
| $932K | 0.04% |
+488,208
| New | +$932K |
|
|
OXFD
143
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $868K | 0.03% |
+51,655
| New | +$868K |
|
144
Pentair
PNR
$17.9B
| $681K | 0.03% |
14,927
-93
| -0.6% | -$4.24K |
|
145
Ashland
ASH
$2.48B
| $663K | 0.03% |
10,126
-72,591
| -88% | -$4.75M |
|
|
SWN
146
DELISTED
Southwestern Energy Company
SWN
| $564K | 0.02% |
92,327
-126,589
| -58% | -$773K |
|
|
NXEOW
147
DELISTED
Nexeo Solutions, Inc. Warrant
NXEOW
| $557K | 0.02% |
1,265,363
-6,900
| -0.5% | -$3.04K |
|
148
Methanex
MEOH
$2.86B
| $510K | 0.02% |
10,126
-46,364
| -82% | -$2.34M |
|
149
Forte Biosciences
FBRX
$137M
| $464K | 0.02% |
+99
| New | +$464K |
|
|
FRC
150
DELISTED
First Republic Bank
FRC
| $454K | 0.02% |
+4,358
| New | +$454K |
|